This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4ncg
From Proteopedia
(Difference between revisions)
OCA (Talk | contribs)
(New page: '''Unreleased structure''' The entry 4ncg is ON HOLD Authors: Yan, Y. Description: Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent...)
Next diff →
Revision as of 07:08, 6 November 2013
Unreleased structure
The entry 4ncg is ON HOLD
Authors: Yan, Y.
Description: Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses
